Psychotropic drugs in dermatologic practice.
D000639:Amitriptyline / Q000627:therapeutic use; D001007:Anxiety / Q000150:complications / Q000188:drug therapy; D001714:Bipolar Disorder / Q000188:drug therapy; D002707:Chlordiazepoxide / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D003702:Delusions / Q000150:complications / Q000188:drug therapy; D003863:Depression / Q000150:complications / Q000188:drug therapy; D003975:Diazepam / Q000627:therapeutic use; D005476:Fluphenazine / Q000627:therapeutic use; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D001523:Mental Disorders / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012652:Self Mutilation / Q000188:drug therapy; D012871:Skin Diseases / Q000150:complications*; D013881:Thioridazine / Q000627:therapeutic use
D011619:Psychotropic Drugs; D000639:Amitriptyline; D002707:Chlordiazepoxide; D008094:Lithium; D013881:Thioridazine; D003975:Diazepam; D005476:Fluphenazine; D002746:Chlorpromazine